fluoxetine has been researched along with Bends in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Querido, AL | 1 |
| Blatteau, JE | 2 |
| de Maistre, S | 1 |
| Lambrechts, K | 1 |
| Abraini, J | 1 |
| Risso, JJ | 2 |
| Vallée, N | 2 |
| Barre, S | 1 |
| Pascual, A | 1 |
| Castagna, O | 1 |
| Abraini, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)[NCT04570449] | Early Phase 1 | 0 participants (Actual) | Interventional | 2020-11-30 | Withdrawn (stopped due to Study timeline is not feasible) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fluoxetine and Bends
| Article | Year |
|---|---|
Diving and antidepressants.
Topics: Antidepressive Agents; Blood Glucose; Decompression Sickness; Diving; Fluoxetine; Hemorrhage; Humans | 2017 |
2 other studies available for fluoxetine and Bends
| Article | Year |
|---|---|
Fluoxetine stimulates anti-inflammatory IL-10 cytokine production and attenuates sensory deficits in a rat model of decompression sickness.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Decompression Sickness; Fluoxet | 2015 |
Protective effects of fluoxetine on decompression sickness in mice.
Topics: Animals; Decompression Sickness; Diving; Embolism, Air; Endothelium, Vascular; Fluoxetine; Humans; M | 2012 |